Antoshechkin A G, Chentsova T V, Naritsin D B, Railian G P
Institute of Molecular Genetics, USSR Academy of Sciences, Moscow.
J Inherit Metab Dis. 1991;14(5):749-54. doi: 10.1007/BF01799945.
By using ion-exchange chromatography and gas chromatography coupled with mass spectrometry, the content of phenylalanine, tyrosine and their metabolites typical of phenylketonuria (PKU) was determined in the cerebrospinal fluid (CSF) of 8 untreated children with classical PKU and 9 controls. At the same time, plasma and urine were analysed. In PKU the content of phenylalanine is increased on average 23 times in plasma and CSF. The content of phenylalanine and tyrosine in CSF is about 4 times less as compared with plasma. The phenylalanine-to-tyrosine ratio is approximately the same for these fluids both in control and in PKU. This indicates that the transport of phenylalanine and tyrosine through the blood-brain barrier is not disturbed in PKU. Phenylpyruvate and 4-hydroxyphenylpyruvate are either not detected or present in very low concentrations in the CSF of children with PKU; their derivatives, phenyllactate and 4-hydroxyphenyllactate, are present in relatively higher concentrations. This indicates increased metabolic conversion in brain tissues.
通过离子交换色谱法以及气相色谱-质谱联用技术,测定了8名未经治疗的典型苯丙酮尿症(PKU)患儿和9名对照儿童脑脊液(CSF)中苯丙氨酸、酪氨酸及其典型的苯丙酮尿症代谢产物的含量。同时,对血浆和尿液进行了分析。在苯丙酮尿症患者中,血浆和脑脊液中苯丙氨酸的含量平均增加了23倍。脑脊液中苯丙氨酸和酪氨酸的含量比血浆中约少4倍。对照人群和苯丙酮尿症患者的这些液体中苯丙氨酸与酪氨酸的比例大致相同。这表明在苯丙酮尿症中,苯丙氨酸和酪氨酸通过血脑屏障的转运并未受到干扰。苯丙酮和4-羟基苯丙酮酸在苯丙酮尿症患儿的脑脊液中要么未被检测到,要么浓度极低;它们的衍生物苯乳酸和4-羟基苯乳酸则以相对较高的浓度存在。这表明脑组织中的代谢转化增加。